Eric K. Rowinsky
- Otorhinolaryngology top 0.05%
- Oncology top 0.02%
- Cancer Treatment and Pharmacology 139
- Colorectal Cancer Treatments and Studies 72
- HER2/EGFR in Cancer Research 58
- Neutropenia and Cancer Infections 40
- Lung Cancer Research Studies 39
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 58
- Cancer Research top 0.2%
- Genetics top 0.2%
-
- Cancer therapeutics and mechanisms 88
-
- Monoclonal and Polyclonal Antibodies Research 23
- Co-authors
- Ross C. DonehowerHagop YoussoufianManuel HidalgoRoger B. CohenJames A. BonnerJ. GiraltPaul M. HarariJosé Baselga
- Journals
- Journal of Clinical Oncology (133 papers)Clinical Cancer Research (32 papers)Investigational New Drugs (17 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Eric K. Rowinsky
394 papers receiving 31.1k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Otorhinolaryngology 3.0k
- Oncology 18.5k
- Pulmonary and Respiratory Medicine 9.6k
- Cancer Research 3.6k
- Genetics 2.0k
Countries citing papers authored by Eric K. Rowinsky
This map shows the geographic impact of Eric K. Rowinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric K. Rowinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric K. Rowinsky more than expected).
Fields of papers citing papers by Eric K. Rowinsky
This network shows the impact of papers produced by Eric K. Rowinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric K. Rowinsky. The network helps show where Eric K. Rowinsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric K. Rowinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 43 | |
| 2 | 2009 | 121 | |
| 3 | 2008 | 227 | |
| 4 | A phase I study of the recombinant human IgG1 anti-IGF-IR monoclonal antibody (Mab) IMC-A12, administered on a weekly basis to patients with advanced solid tumors: Interim analysis | 2007 | 9 |
| 5 | Phase I dose-escalation study of the anti-VEGFR-2 recombinant human IgG1 MAb IMC-1121B administered every other week (q2w) or every 3 weeks (q3w) in patients (pts) with advanced cancers | 2007 | 12 |
| 6 | 2006 | 34 | |
| 7 | Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2006 | 794 |
| 8 | 2006 | 109 | |
| 9 | Phase I study of BMS-247550, an epothilone B analog, administered weekly for 3 weeks followed by a one-week break in patients (pts) with advanced malignancies | 2006 | 3 |
| 10 | 2006 | 32 | |
| 11 | Analysis of dose proportionality testing methods in phase I clinical trials of anticancer agents | 2005 | 1 |
| 12 | 2003 | 62 | |
| 13 | 2003 | 7 | |
| 14 | 2000 | 12 | |
| 15 | 1998 | 17 | |
| 16 | 1996 | 151 | |
| 17 | 1995 | 201 | |
| 18 | Paclitaxel in cancer treatment | 1995 | 37 |
| 19 | Phase I and pharmacokinetic study of brequinar sodium (NSC 368390). | 1990 | 32 |
| 20 | Microtubule changes and cytotoxicity produced by taxol in human ovarian cell lines | 1987 | 1 |
About Eric K. Rowinsky
Eric K. Rowinsky is a scholar working on Oncology, Genetics and Hematology, having authored 396 papers that have together received 32.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (139 papers), Cancer therapeutics and mechanisms (88 papers), Colorectal Cancer Treatments and Studies (72 papers), HER2/EGFR in Cancer Research (58 papers), Lung Cancer Treatments and Mutations (58 papers), Neutropenia and Cancer Infections (40 papers), Lung Cancer Research Studies (39 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). The work is most often cited by research in Otorhinolaryngology (3.0k citations), Oncology (18.5k citations) and Pulmonary and Respiratory Medicine (9.6k citations). Eric K. Rowinsky has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Ross C. Donehower, Hagop Youssoufian, Manuel Hidalgo, Roger B. Cohen, James A. Bonner, J. Giralt, Paul M. Harari, José Baselga, Ranjan Sur and David Raben. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Investigational New Drugs, Blood and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.